Healthcare Stocks News 1 December 2025

Centene (CNC) Stock Jumps on Baird Upgrade: What December 11, 2025 Means for the Outlook and Forecasts

Centene Corporation (NYSE: CNC) has snapped back into the spotlight. On December 11, 2025, Centene stock surged above $40 after Robert W. Baird lifted its price target from $28 to $36 while maintaining a neutral rating. The move added to

11 December 2025

Financial Forecasts·Healthcare Stocks·Investment Strategies·Market Outlook·Stock Analysis

Johnson & Johnson (JNJ) Stock Near Record Highs: Latest News, Legal Risks and 2026 Outlook for Investors

Johnson & Johnson stock has gone from sleepy blue chip to market star in 2025. As of the morning of December 11, 2025, JNJ trades around $208 per share, sits at an estimated $500+ billion market capitalization, and is at

11 December 2025

Healthcare Stocks·Investment Strategies·Legal Issues·Market Outlook·Stock Market

HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views

As of December 11, 2025, HeartBeam, Inc. (NASDAQ: BEAT) has abruptly moved from obscure micro‑cap to one of the hottest tickers in medtech, after winning a pivotal U.S. FDA clearance for its cable‑free, at‑home 12‑lead ECG synthesis software. The stock

11 December 2025

FDA News·Financial Forecasts·Healthcare Stocks·Investment Analysis·Stock Market

Biotech Stocks Today: FDA Shifts, ASH 2025 Winners and Market Close Recap (December 9, 2025)

Biotech investors faced a dense catalyst calendar on Tuesday, December 9, 2025, as new U.S. Food and Drug Administration (FDA) signals on cell and gene therapy, fresh designations in hematologic cancers and high‑impact clinical data from the American Society of

9 December 2025

Biotech·Healthcare Stocks

Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems, Inc. (NYSE: INSP), a leading developer of implantable devices to treat obstructive sleep apnea, is back in the spotlight. As of December 9, 2025, the stock is trading near the upper end of its recent rebound, supported

9 December 2025

Analyst Ratings·Healthcare Stocks·Investment Analysis·Legal News·Stock Market

UnitedHealth Group (UNH) Stock: 2026 Comeback Hopes After a Brutal 2025 – What Investors Need to Know Today (December 8, 2025)

UnitedHealth Group (NYSE: UNH) stock is trading in the low‑$300s after a year of surging medical costs, a record‑breaking cyberattack and fresh DOJ scrutiny. With raised 2025 EPS guidance, a 2.7% dividend yield and Wall Street seeing mid‑teens upside, is

8 December 2025

Financial News·Healthcare Stocks·Investment Trends·Stock Market

UnitedHealth Group (UNH) Stock: What to Know Before the Market Opens on December 8, 2025

Published: December 7, 2025 UnitedHealth Group Incorporated (NYSE: UNH) heads into Monday’s U.S. session still in “repair mode” after one of the most bruising years in its modern history. Yet fresh analyst upgrades, stabilizing fundamentals and a key dividend date

7 December 2025

Financial News·Healthcare Stocks·Investing·Market Analysis·Stock Market

UNH Stock Outlook on December 6, 2025: Can UnitedHealth’s Turnaround Power a 2026 Rebound?

Published: December 6, 2025 — Informational, not investment advice. UnitedHealth Group’s stock (NYSE: UNH) heads into the weekend trading around $330.91 per share, after a choppy week where it helped drive both rallies and sell-offs in the Dow Jones Industrial

6 December 2025

Financial Forecasts·Healthcare Stocks·Investment Strategies·Market Trends·Stock Analysis

Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare Inc. (Nasdaq: IXHL) is back on traders’ radar after the U.S. Food and Drug Administration granted Fast Track designation to its lead sleep-apnoea drug candidate, IHL‑42X. The move caps a busy 2025 that also brought strong Phase 2

4 December 2025

FDA News·Healthcare Stocks·Investment Forecasts·Risk Analysis·Stock Market

Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health (NYSE: CAH) stock has cooled off after a powerful run in 2025, raising a key question for investors: is this just a healthy pullback, or the start of something more serious? Below is a detailed, news-driven look at

4 December 2025

Financial News·Healthcare Stocks·Investment Strategies·Market Analysis·Stock Market

Smith & Nephew (SN, SNN) Stock Outlook for December 2025: Q3 Setback, $500m Buyback and What Comes Next

London – 2 December 2025 – Smith & Nephew plc (LSE: SN., NYSE: SNN) heads into the final weeks of 2025 as a classic “turnaround in progress” story: margins are rising, cash generation is strong and a $500 million buyback

2 December 2025

Financial News·Healthcare Stocks·Investment Strategies·Market Outlook·Stock Analysis

HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

Date: December 1, 2025 – NYSE: HCA HCA Healthcare stock snapshot on December 1, 2025 HCA Healthcare, Inc. (NYSE: HCA), the largest for‑profit hospital operator in the United States, continues to trade near record territory as December begins. Barchart’s latest

1 December 2025

Financial News·Healthcare Stocks·Investment Analysis·Market Trends·Stock Market

Healthcare Stocks News 1 December 2025 - 11 December 2025